Low adoption of pharmacogenetic testing: an exploration and explanation of the reasons in Australia

摘要: The research reported here sought to identify and illuminate the reasons for low adoption of pharmacogenetic tests in Australia. initially established possible propositions drawn from previous studies surveys on problem Europe literature innovations. A small-scale exploratory, qualitative study was undertaken one state Australia; clinicians other stake-holders were interviewed about their use or support tests. expected, quite extensive individual factors known influence rejection innovations found be present situations covered. nonadoption that also supported. Some other, possibly critical, identified. implications this initial exploration are discussed prospects increased proposed.